Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis
Background This review aims to evaluate the safety and efficacy of apixaban vs. vitamin K antagonists (VKAs) in patients on dialysis.Methods All types of studies published on PubMed, Embase, CENTRAL, and Web of Science up to 10 September 2023 and comparing outcomes of apixaban vs. VKA in dialysis pa...
Saved in:
| Main Authors: | Yifang Zhang, Jialiang Wang, Nannan Shen, Jie Jiang, Yanna Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2349114 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-analysis comparing apixaban versus warfarin anticoagulation therapies for patients with severe renal insufficiency
by: LIANG Qiao-jing, et al.
Published: (2019-01-01) -
Safety and efficacy of apixaban in patients with glomerulonephritis and nephrotic syndrome: a prospective longitudinal cohort study
by: I. S. Mykhaloiko, et al.
Published: (2025-03-01) -
Oral anticoagulants versus vitamin K antagonists in the treatment of non-valvular atrial fibrillation in patients with stage 4-5 chronic kidney disease
by: E. G. Skorodumova, et al.
Published: (2024-04-01) -
Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01) -
Risk of postoperative bleeding following dental extractions in patients on antithrombotic treatment
by: Mohammed AlSheef, et al.
Published: (2021-11-01)